Trial Profile
A study to evaluate clinical and biochemical characteristics of patients with vertebral fractures following denosumab discontinuation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis; Vertebral fracture
- Focus Pharmacodynamics
- 10 Jul 2017 New trial record